These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26703965)

  • 21. Significant Quantitative Differences in Orexin Neuronal Activation After Pain Assessments in an Animal Model of Sickle Cell Disease.
    Richardson K; Sweatt N; Tran H; Apprey V; Uthayathas S; Taylor R; Gupta K
    Front Mol Biosci; 2020; 7():5. PubMed ID: 32118032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain.
    Toth CC; Jedrzejewski NM; Ellis CL; Frey WH
    Mol Pain; 2010 Mar; 6():16. PubMed ID: 20236533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heme Causes Pain in Sickle Mice
    Lei J; Paul J; Wang Y; Gupta M; Vang D; Thompson S; Jha R; Nguyen J; Valverde Y; Lamarre Y; Jones MK; Gupta K
    Antioxid Redox Signal; 2021 Feb; 34(4):279-293. PubMed ID: 32729340
    [No Abstract]   [Full Text] [Related]  

  • 24. Mast Cell-Mediated Mechanisms of Nociception.
    Aich A; Afrin LB; Gupta K
    Int J Mol Sci; 2015 Dec; 16(12):29069-92. PubMed ID: 26690128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia.
    Akopian AN; Ruparel NB; Jeske NA; Patwardhan A; Hargreaves KM
    Trends Pharmacol Sci; 2009 Feb; 30(2):79-84. PubMed ID: 19070372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of capsaicin-sensitive nerves and tachykinins in mast cell tryptase-induced inflammation of murine knees.
    Borbély É; Sándor K; Markovics A; Kemény Á; Pintér E; Szolcsányi J; Quinn JP; McDougall JJ; Helyes Z
    Inflamm Res; 2016 Sep; 65(9):725-36. PubMed ID: 27251170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal glial activation and oxidative stress are alleviated by treatment with curcumin or coenzyme Q in sickle mice.
    Valverde Y; Benson B; Gupta M; Gupta K
    Haematologica; 2016 Feb; 101(2):e44-7. PubMed ID: 26546503
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune cell neural interactions and their contributions to sickle cell disease.
    Sagi V; Mittal A; Gupta M; Gupta K
    Neurosci Lett; 2019 Apr; 699():167-171. PubMed ID: 30738871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid control of neurogenic inflammation.
    McKenna M; McDougall JJ
    Br J Pharmacol; 2020 Oct; 177(19):4386-4399. PubMed ID: 33289534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potamotrygon motoro stingray venom induces both neurogenic and inflammatory pain behavior in rodents.
    Kimura LF; Santos-Neto M; Barbaro KC; Picolo G
    Toxicon; 2018 Aug; 150():168-174. PubMed ID: 29803862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting pain at its source in sickle cell disease.
    Gupta K; Jahagirdar O; Gupta K
    Am J Physiol Regul Integr Comp Physiol; 2018 Jul; 315(1):R104-R112. PubMed ID: 29590553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.
    Comelli F; Giagnoni G; Bettoni I; Colleoni M; Costa B
    Phytother Res; 2008 Aug; 22(8):1017-24. PubMed ID: 18618522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatiotemporal Alterations in Gait in Humanized Transgenic Sickle Mice.
    Kiven S; Wang Y; Aich A; Argueta DA; Lei J; Sagi V; Tennakoon M; Bedros SJ; Lambrecht N; Gupta K
    Front Immunol; 2020; 11():561947. PubMed ID: 33178189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist.
    Amaya F; Shimosato G; Kawasaki Y; Hashimoto S; Tanaka Y; Ji RR; Tanaka M
    Pain; 2006 Sep; 124(1-2):175-83. PubMed ID: 16709443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
    Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting the cannabinoid system to produce analgesia.
    Sagar DR; Jhaveri M; Chapman V
    Curr Top Behav Neurosci; 2009; 1():275-87. PubMed ID: 21104388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation.
    De Filippis D; D'Amico A; Iuvone T
    J Neuroendocrinol; 2008 May; 20 Suppl 1():20-5. PubMed ID: 18426495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.
    Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z
    Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.